Wolfgang Timmer
Heidelberg University
11 Papers
99 Citations
Wolfgang Timmer is an academic researcher from Heidelberg University. The author has contributed to research in topics: Medicine & Provocation test. The author has an hindex of 9, co-authored 11 publications.
Chat about Author
Papers
Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.
Norbert Krug,Jens M. Hohlfeld,Anne-Marie Kirsten,Oliver Kornmann,Kai Michael Beeh,Dominik Kappeler,Stephanie Korn,Stanislav Ignatenko,Wolfgang Timmer,Cordelia Rogon,Jana Zeitvogel,Nan Zhang,Joachim Bille,Ursula Homburg,Agnieszka Turowska,Claus Bachert,Thomas Werfel,Roland Buhl,Jonas Renz,Holger Garn,Harald Renz +20 more
TL;DR: Treatment with SB010 significantly attenuated both late and early asthmatic responses after allergen provocation in patients with allergic asthma, and biomarker analysis showed an attenuation of Th2-regulated inflammatory responses.
The New Phosphodiesterase 4 Inhibitor Roflumilast Is Efficacious in Exercise‐Induced Asthma and Leads to Suppression of LPS‐Stimulated TNF‐α Ex Vivo
Wolfgang Timmer,Violette Leclerc,Guillaume Birraux,Markus Neuhäuser,Armin Hatzelmann,T.D. Bethke,Wilhelm Wurst +6 more
TL;DR: It is concluded that roflumilast is effective in the treatment of exercise‐induced asthma, accompanied by a significant reduction of TNF‐α levels ex vivo.
129
The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis
Bernhard Schmidt,Matthias Kusma,Martin Feuring,Wolfgang Timmer,Markus Neuhäuser,T.D. Bethke,Boris A. Stuck,Karl Hörmann,Martin Wehling +8 more
TL;DR: This study shows that a PDE4 inhibitor, roflumilast, effectively controls symptoms of allergic rhinitis and might be a future treatment option not only in allergic asthma but also in allergicrhinitis or the combination of the 2 diseases.
96
Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide.
Anita Weinbrenner,Dagny Hüneke,Zschiesche M,Georg P. Engel,Wolfgang Timmer,Volker W. Steinijans,T.D. Bethke,Wilhelm Wurst,Anton Drollmann,Hans Joachim Kaatz,Werner Siegmund +10 more
TL;DR: In conclusion, inhaled ciclesonide in daily doses of 800 microg for 7 d is without clinically relevant effects on the hypothalamic-pituitary-adrenal axis independent of the time of administration.
The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis
Bernhard Schmidt,Wolfgang Timmer,Anette C. Georgens,Monika Hilt,Catherine Mattinger,Wilhelm Wurst,Karl Hörmann,Martin Wehling +7 more
TL;DR: The results of this study clearly indicate that the new topical steroid ciclesonide is effective in the treatment of allergic rhinitis without producing local or systemic side effects.
65